Mofecon S 360mg Tablet

About

Mycophenolate Mofetil (MMF) is a potent immunosuppressive agent widely employed in transplant medicine to prevent the rejection of solid organ transplants, including kidney, heart, and liver allografts. Its mechanism of action involves the selective inhibition of inosine monophosphate dehydrogenase (IMPDH), a crucial enzyme in the de novo pathway of guanosine nucleotide synthesis. This inhibition specifically targets and suppresses the proliferation of T and B lymphocytes, which are key immune cells responsible for mediating organ rejection. By selectively depleting these activated lymphocytes, MMF effectively dampens the immune system's response against the transplanted organ, thereby significantly reducing the incidence of acute rejection episodes and improving long-term graft survival. It is frequently administered in combination with other immunosuppressants, such as calcineurin inhibitors and corticosteroids, to achieve optimal immunosuppression.

Uses

• Prevention of organ rejection in kidney transplant patients.
• Prevention of organ rejection in heart transplant patients.
• Prevention of organ rejection in liver transplant patients.
• Treatment of certain autoimmune diseases (off-label use).

Directions For Use

Take this tablet orally, usually twice daily, with a glass of water, as directed by your physician. Do not crush or chew the tablets.

Benefits

• Effectively prevents organ transplant rejection.
• Reduces the incidence of acute rejection episodes.
• Often used in combination for enhanced immunosuppression.
• Improves long-term graft survival.
• Helps maintain the function of transplanted organs.
• Well-established in transplant protocols.

Side Effects

• Diarrhea
• Nausea
• Vomiting
• Abdominal pain
• Leukopenia (low white blood cell count)
• Anemia
• Thrombocytopenia (low platelet count)
• Increased risk of infections
• Increased risk of certain cancers (lymphoma)
• Headache
• Tremor
• High blood pressure

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may exacerbate gastrointestinal side effects and potentially increase the risk of liver toxicity.
• Pregnancy - Mycophenolate mofetil is highly teratogenic and contraindicated in pregnancy due to severe birth defects; effective contraception is mandatory.
• Breastfeeding - Mycophenolate mofetil is excreted into breast milk and can cause serious adverse effects in the infant; therefore, breastfeeding is contraindicated.
• Liver - Use with caution in patients with severe liver impairment, as it may alter drug metabolism and increase systemic exposure; dose adjustments may be needed.
• Kidney - Use with caution in patients with severe chronic kidney impairment, as dose adjustments may be necessary, and close monitoring is required.
• Lung - Mycophenolate mofetil can rarely cause interstitial lung disease or pulmonary fibrosis; monitor for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.